AnalystsBill MaughanBill Maughan's Stock Forecasts
AnalystsBill Maughan
Sectors:
Industries:
Analyst Ranking
Bottom 12%
#4316 out of 4870 analysts
Average Return
-45.19%
Win Rate
13%1 out of 8
Risk vs Reward
Poor
Good
Bill Maughan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Merus NvMRUS | +129.26% | $21.94 | $50.30 | 2023-11-01 - 2024-11-01 | Strong Buy |
Bill Maughan Analyst Color
Get additional color on Bill Maughan's coverage of popular stocks
Bill Maughan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Y Mabs Therapeutics IncYMAB | 2 | Strong Buy | $26.00 | +532.60% | Maintains | 9 months ago |
Nkarta IncNKTX | 2 | Strong Buy | $15.00 | +631.71% | Maintains | a year ago |
Fate Therapeutics IncFATE | 1 | Strong Buy | $9.00 | +625.81% | Maintains | a year ago |
Immunocore Holdings PLCIMCR | 3 | Hold | $67.00 | +122.22% | Maintains | a year ago |
Moderna IncMRNA | 3 | Hold | $106.00 | +292.16% | Maintains | a year ago |
Century Therapeutics IncIPSC | 1 | Strong Buy | $24.00 | N/A | Maintains | a year ago |
Bicycle Therapeutics PLCBCYC | 1 | Strong Buy | $60.00 | N/A | Reiterates | a year ago |
Merus NvMRUS | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.